NCT05977569

Brief Summary

This study aims to establish the metabolic/molecular response in both adipose tissue and skeletal muscle as well as sensory experiences (pain, fatigue, drive) to prolonged fasting of 3 days duration. Participants will undergo sequential meal assessment before and after a 3 day fast with measures taken throughout each fasting day.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
7

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 28, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 7, 2021

Completed
1.9 years until next milestone

First Posted

Study publicly available on registry

August 4, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2024

Completed
Last Updated

August 4, 2023

Status Verified

July 1, 2023

Enrollment Period

2.9 years

First QC Date

September 7, 2021

Last Update Submit

July 26, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in postprandial insulin responses

    Change in postprandial insulin (mmol/L) response to a standardised meal before and after 3 days of fasting.

    3 days

Secondary Outcomes (13)

  • Change in circulating glycerol and non-esterified fatty acids

    1 day, 2 days, 3 days

  • Change in Autophagy

    3 days

  • Change in plasma lactate

    1 day, 2 days, 3 days

  • Change in plasma pyruvate

    1 day, 2 days, 3 days

  • Change in ketosis.

    1 day, 2 days, 3 days.

  • +8 more secondary outcomes

Study Arms (1)

Prolonged Fasting

EXPERIMENTAL

All participants are asked to act as their own control prior to being asked to undergo 3 days of fasting.

Other: Prolonged Fasting

Interventions

Participants are asked to refrain from caloric intake for 3 days following a period of habitual lifestyle assessment and metabolic assessment.

Prolonged Fasting

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Body mass index 20.0-29.9 kg∙m-2
  • Age 18-45 years
  • Willing to abstain from food intake for just over 3 days (\~82 hours)
  • Able and willing to provide informed consent and safely comply with study procedures
  • Females to maintain record of regular menstrual cycle phase or contraceptive use
  • No anticipated changes in lifestyle during the study (e.g. holidays or exercise programmes)

You may not qualify if:

  • Any reported condition or behaviour deemed either to pose undue personal risk to the participant or introduce bias
  • Any diagnosed metabolic disease (e.g. type 1 or type 2 diabetes)
  • Any reported use of substances which may pose undue personal risk to the participants or introduce bias into the experiment
  • Pregnancy
  • Breastfeeding
  • Lifestyle not conforming to standard sleep-wake cycle (e.g. shift worker)
  • History of eating disorders (e.g. anorexia)
  • Any reported recent (\<6 months) change in body mass (± 3%)
  • Uncontrolled hyperthyroidism
  • Advanced cerebrovascular insufficiency or dementia
  • Advanced liver or kidney insufficiency
  • History of migraine and or headache
  • Psychotic disorders
  • Unstable or severe coronary artery disease
  • Retinal detachment
  • +9 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Bath

Bath, Somerset, BA2 7AY, United Kingdom

Location

MeSH Terms

Conditions

FastingObesity

Condition Hierarchy (Ancestors)

Feeding BehaviorBehaviorOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 7, 2021

First Posted

August 4, 2023

Study Start

June 28, 2021

Primary Completion

May 30, 2024

Study Completion

May 30, 2024

Last Updated

August 4, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations